4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-17-006713
Options or other derivatives
- Chief Medical Officer acquired 155,656 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Clark David J Chief Medical Officer | 2017-03-03 | Grant or award · Employee Stock Option (Right to Buy) | +155,656 | 155,656 | D | ||
Loading xslF345X03/doc4.xml…